Latest Press Releases View all Jun 05, 2026 Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference Jun 03, 2026 Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10 Jun 01, 2026 Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy View all Featured Media Library Items View all Reshma Kewalramani, M.D. Chief Executive Officer and President Download Duncan McKechnie Executive Vice President and Chief Commercial Officer Download Vertex International Headquarters – Lobby Download View all
Jun 03, 2026 Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10
Jun 01, 2026 Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy